heart failure glp-1 Pharmacological treatment for patients with obesity and failure: Focus on glucagon‐like peptide‐1 receptor agonists. European Journal of Heart expert consensus document - Monzo - 2025 GLP-1 receptor agonists as promising

For the comparison of known physical interaction partners of the viral proteome with tier-1 and tier-2 targets (Fig

TGF, transforming growth factor

Any misuse outside approved research context is strictly prohibited and may be illegal

4,5 The primary endogenous GLP-1R agonist is the fully processed peptide, GLP-1(7-36)-NH 2

Two classes of ferroptosis-inducing compounds were investigated (Fig

There are conflicting recommendations[45][47] regarding whether to change the dosing of oral acetylcysteine after the administration of activated carbon, and even whether the dosing of acetylcysteine needs to be altered at all